Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
therapeutics crawled date : 2023 - 02 - 02 save search
Gilead Sciences Announces Fourth Quarter and Full Year 2022 Financial Results
Published: 2023-02-02 (Crawled : 23:00) - biospace.com/
ACLX | $54.5 1.77% 1.74% 600K
|
|
| O: 0.15%
H: 2.24%
C: 2.21%
RCUS 4 | $14.84 0.0% 910K
|
Health Technology
|
| O: -6.12%
H: 4.9%
C: 0.76%
MGNX | $16.07 -0.19% -0.12% 660K
|
Health Technology
|
| O: -0.5%
H: 2.87%
C: 0.0%
JNCE | $1.88 -2.59% -1.85% 0
|
Health Technology
|
| O: 3.36%
H: 2.44%
C: -1.63%
GILD | News | $66.16 -1.15% -1.16% 4.9M
|
Health Technology
|
| O: -1.95%
H: 0.16%
C: -1.18%
sciences year financial results
Post Holdings Reports Results for the First Quarter of Fiscal Year … – GlobeNewswire
Published: 2023-02-02 (Crawled : 23:00) - spacfeed.com
IPSI | $0.1484 6.0% -92.67% 170
|
Retail Trade
|
| O: -9.09%
H: 10.0%
C: 6.0%
year
S-4/A – Rice Acquisition Corp. II (0001845437) (Filer)
Published: 2023-02-02 (Crawled : 23:00) - spacfeed.com
TENX | $3.67 2.23% 2.18% 21K
|
Health Technology
|
| O: -23.08%
H: 9.41%
C: 2.94%
acquisition rice
Technology leads the charge yet again
Published: 2023-02-02 (Crawled : 23:00) - spacfeed.com
CETY | News | $1.45 -2.03% -3.14% 64K
|
Manufacturing
| Email alert
Add to watchlist
GPCR | $36.18 -2.4% -2.52% 380K
|
n/a
| Email alert
Add to watchlist
SCMA | $10.39 -5.37% 0.0% 0
|
| Email alert
Add to watchlist
technology
Deals Rumor Mill: Bed Bath & Beyond, Stripe, Twitter – Law360
Published: 2023-02-02 (Crawled : 23:00) - spacfeed.com
CETY | News | $1.45 -2.03% -3.14% 64K
|
Manufacturing
| Email alert
Add to watchlist
GPCR | $36.18 -2.4% -2.52% 380K
|
n/a
| Email alert
Add to watchlist
SCMA | $10.39 -5.37% 0.0% 0
|
| Email alert
Add to watchlist
PTC Therapeutics to Participate at Upcoming Investor Conference
Published: 2023-02-02 (Crawled : 22:00) - prnewswire.com
PTCT | $24.71 -1.79% -1.82% 820K
|
Health Technology
|
| O: -1.06%
H: 2.94%
C: 2.52%
conference therapeutics
Patent Trial and Appeal Board (PTAB) Reaffirms Decision to Invalidate All Claims of United Therapeutics (UTHR) Patent No. 10,716,793 (‘793 Patent)
Published: 2023-02-02 (Crawled : 22:00) - globenewswire.com
UTHR | $236.93 0.69% 0.78% 480K
|
Health Technology
|
| O: -0.1%
H: 1.37%
C: -2.48%
LQDA M | $13.81 -0.36% -0.36% 670K
|
Health Technology
|
| O: 1.71%
H: 3.37%
C: 0.0%
patent trial therapeutics
Sorrento Issues Supplement to its Previously Issued “FAQ” Regarding the Dividend of Scilex Holding Company Common Stock
Published: 2023-02-02 (Crawled : 20:00) - globenewswire.com
SCLX | $0.8942 -23.57% -30.84% 2.8M
|
|
| O: -1.41%
H: 7.28%
C: 0.39%
BNPQF | $68.558 -13.4% 400
|
Finance
|
| O: -3.56%
H: 0.0%
C: -2.73%
BNPQY | $34.61 1.05% -2.68% 100K
|
Finance and Insurance
|
| O: -0.75%
H: 0.75%
C: -0.18%
UBS J | $28.12 0.04% 0.0% 2.3M
|
Finance
|
| O: -0.88%
H: 1.58%
C: 0.93%
MS | News 0 d | $90.26 0.2% -0.31% 5.1M
|
Finance
|
| O: -0.98%
H: 1.97%
C: 1.21%
SRNE | $0.024 -14.29% -8.85% 57K
|
Health Technology
|
| O: -1.96%
H: 6.0%
C: 2.0%
AMAL | $21.575 0.4% 0.39% 80K
|
Finance
|
| O: -0.17%
H: 0.35%
C: 0.13%
Scilex Holding Company Announces that its Majority Stockholder, Sorrento Therapeutics, Inc., has Issued a Supplement to its Previously Issued “FAQ” Regarding the Dividend of Scilex Holding Company Common Stock
Published: 2023-02-02 (Crawled : 19:00) - globenewswire.com
SCLX | $0.8942 -23.57% -30.84% 2.8M
|
|
| O: -1.41%
H: 7.28%
C: 0.39%
BNPQF | $68.558 -13.4% 400
|
Finance
|
| O: -3.56%
H: 0.0%
C: -2.73%
BNPQY | $34.61 1.05% -2.68% 100K
|
Finance and Insurance
|
| O: -0.75%
H: 0.75%
C: -0.18%
XYF | News | $3.78 -0.26% 0.0% 4.9K
|
Finance
|
| O: 0.06%
H: 3.32%
C: 0.51%
UBS J | $28.12 0.04% 0.0% 2.3M
|
Finance
|
| O: -0.88%
H: 1.58%
C: 0.93%
USB | $39.44 -0.2% -0.48% 9.9M
|
Finance
|
| O: -0.67%
H: 1.63%
C: 0.98%
MS | News 0 d | $90.26 0.2% -0.31% 5.1M
|
Finance
|
| O: -0.98%
H: 1.97%
C: 1.21%
DB | $15.8 0.83% 0.82% 7.4M
|
Finance
|
| O: -0.64%
H: 0.6%
C: -0.56%
SRNE | $0.024 -14.29% -8.85% 57K
|
Health Technology
|
| O: -1.96%
H: 6.0%
C: 2.0%
AMAL | $21.575 0.4% 0.39% 80K
|
Finance
|
| O: -0.17%
H: 0.35%
C: 0.13%
Sage Therapeutics to Report Fourth Quarter and Full Year 2022 Financial Results on Thursday, February 16, 2023
Published: 2023-02-02 (Crawled : 17:00) - biospace.com/
SAGE | $13.035 3.7% 3.53% 1.6M
|
Health Technology
|
| O: 0.96%
H: 0.0%
C: -1.11%
report year therapeutics financial results
Y-mAbs and the European Medicines Agency Reach Agreement on the Pediatric Investigation Plan for Naxitamab
Published: 2023-02-02 (Crawled : 16:00) - biospace.com/
YMAB | $15.0 -0.73% -0.94% 410K
|
Health Technology
|
| O: 0.43%
H: 4.29%
C: 3.43%
agreement
Coya Therapeutics, Inc. to Present Proof of Concept Clinical Data at Multiple Scientific Conferences Throughout 2023
Published: 2023-02-02 (Crawled : 16:00) - biospace.com/
COYA | News | $8.53 3.52% 3.4% 30K
|
|
| O: 5.5%
H: 0.73%
C: -3.66%
The Global Antipsychotic Drugs Market to Register Growth at a CAGR of ~7% by 2027 | DelveInsight
Published: 2023-02-02 (Crawled : 16:00) - prnewswire.com
ATAI | $1.91 -3.54% -3.66% 1M
|
Manufacturing
|
| O: 1.63%
H: 6.95%
C: 4.81%
VTRS | $11.12 0.18% 0.09% 2.3M
|
Health Technology
|
| O: -0.16%
H: 0.08%
C: -0.41%
BMY | $48.3 0.96% 0.33% 8.9M
|
Health Technology
|
| O: -1.28%
H: 3.64%
C: 3.48%
ABBV | News | $164.66 0.25% -0.14% 3.6M
|
Health Technology
|
| O: -0.46%
H: 0.0%
C: -0.75%
ACER | $0.9 -3.61% 420K
|
Health Technology
|
| O: -0.88%
H: 2.65%
C: -3.98%
global growth market
Compass Therapeutics to Participate in the SVB Securities Global Biopharma Conference
Published: 2023-02-02 (Crawled : 15:20) - biospace.com/
CMPX | $1.49 -2.61% -2.0% 170K
|
Professional, Scientific, and T...
|
| O: 4.76%
H: 1.32%
C: -5.02%
biopharma global conference therapeutics
Gain Therapeutics to Participate in Upcoming Scientific and Medical ConferencesGain to present new preclinical data on its lead programs in GBA1-related diseases
Published: 2023-02-02 (Crawled : 15:00) - biospace.com/
GANX | $3.15 -0.94% -0.95% 78K
|
Professional, Scientific, and T...
|
| O: 3.27%
H: 0.98%
C: -5.61%
preclinical medical therapeutics
GT Biopharma Issues Open Letter to Shareholders Detailing Recent Activities
Published: 2023-02-02 (Crawled : 15:00) - globenewswire.com
GTBP | $3.97 1.3% 1K
|
Manufacturing
|
| O: 6.25%
H: 11.76%
C: -1.18%
FATE | $5.04 -4.36% -4.56% 2.3M
|
Health Technology
|
| O: 2.98%
H: 7.01%
C: 4.12%
biopharma
Vistagen Announces Closing of Pherin Pharmaceuticals Acquisition
Published: 2023-02-02 (Crawled : 14:20) - biospace.com/
VTGN | $4.69 0.43% 0.43% 200K
|
Health Technology
|
| O: 3.55%
H: 14.92%
C: 5.18%
acquisition pharmaceuticals
Unicycive Announces Exclusive License and Development Agreement with Lotus for Renazorb in the Republic of Korea
Published: 2023-02-02 (Crawled : 14:00) - globenewswire.com
UNCY | $1.09 -5.63% -5.96% 890K
|
Professional, Scientific, and T...
|
| O: 0.24%
H: 5.16%
C: -7.27%
license agreement renazorb
Guardant Health and AnHeart Therapeutics Announce Collaboration to Develop Guardant360® CDx and Guardant360 Tissue
Published: 2023-02-02 (Crawled : 14:00) - biospace.com/
GH M | $16.67 1.71% 1.74% 1.6M
|
Health Services
|
| O: 3.0%
H: 4.19%
C: -1.76%
guardant360 collaboration health therapeutics
Repare Therapeutics to Participate in Two Upcoming Investor Conferences - February 2, 2023
Published: 2023-02-02 (Crawled : 13:20) - biospace.com/
RPTX 4 | $3.02 -5.92% -6.12% 140K
|
Health Technology
|
| O: 0.87%
H: 5.59%
C: 3.38%
therapeutics
Gainers vs Losers
| 61% | 39% |
Top 10 Gainers
AGBA | News | $1.02 155.0% 57.94% 120M
|
Finance
ZCMD | $1.45 5.84% 52.1% 2.3M
|
Commercial Services
INVO | $1.555 104.6% 51.13% 5M
|
Health Technology
ISPC | $0.421 97.65% 49.53% 37M
|
Professional, Scientific, and T...
WLGS | News | $0.92 84.0% 45.65% 1.6M
|
OST | $0.509 23.81% 45.26% 90K
|
GDHG | $0.263 21.76% 40.66% 3.1M
|
XPON | News | $3.15 63.21% 37.74% 16M
|
TIRX | $0.8 65.02% 30.74% 58M
|
BNTC | News | $6.92 44.17% 30.64% 3.5M
|
Health Technology
Your saved searches
Save your searches and get alerts when important news are released.